NABRIVA THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NBRVF and buy or sell other stocks, ETFs, and their options commission-free!About NBRVF
Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the commercialization and development of novel anti-infective agents to treat infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
CEOH. Michael Hogan
CEOH. Michael Hogan
Employees39
Employees39
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees39
Employees39
NBRVF Key Statistics
Market cap323.08
Market cap323.08
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume107.11
Average volume107.11
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume235.00
Volume235.00
52 Week high$0.01
52 Week high$0.01
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
NABRIVA THERAPEUTICS(NBRVF) stock is priced at $0.00, giving the company a market capitalization of 323.08.
During the trading session on 2025-12-08, NABRIVA THERAPEUTICS(NBRVF) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 235, compared to an average daily volume of 107.11.
The stock's 52-week range extends from a low of $0.00 to a high of $0.01.
The stock's 52-week range extends from a low of $0.00 to a high of $0.01.
People also own
Based on the portfolios of people who own NBRVF. This list is generated using Robinhood data, and it’s not a recommendation.